Agillic (AGILC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
23 Apr, 2026Executive summary
Achieved strong Q1 results with EBITDA of DKK 2.5 million, up 213% YoY, and ARR from subscriptions up 6% YoY to DKK 57.5 million, driven by new client inflow and reduced churn.
Cash flow from operations increased to DKK 4.5 million, up DKK 2.6 million YoY, reflecting improved operational results and optimized working capital.
Financial highlights
Subscription revenue rose 4% YoY to DKK 13.1 million, while total revenue declined 3% YoY due to a 51% drop in transaction revenue.
Gross profit increased 2% YoY to DKK 12.2 million, with gross margin improving to 86% from 82% YoY.
EBITDA margin reached 17.6%, up from 5.4% YoY, reflecting cost reductions and structural changes.
Net profit improved to a loss of DKK -1.3 million from DKK -3.0 million YoY.
Cash position at quarter-end was DKK 2.7 million, down from DKK 5.2 million YoY.
Outlook and guidance
Guidance for 2026 remains unchanged: 5-10% growth in ARR subscriptions, 12-18% EBITDA margin, and positive free cash flow for the year.
Full-year ARR growth expected to accelerate due to a strong pipeline and go-to-market initiatives.
Latest events from Agillic
- Q3 saw revenue and ARR declines but positive EBITDA, strong cash flow, and stable guidance.AGILC
Q3 20249 Mar 2026 - Revenue and ARR fell, but net profit and EBITDA improved on tax credit and cost control.AGILC
Q2 20243 Mar 2026 - ARR fell but EBITDA and cash flow improved, with a strategic shift to Nordic growth.AGILC
Q4 20243 Mar 2026 - ARR up 4% and EBITDA up 20% in Q1 2025, with improved cash flow and stable guidance.AGILC
Q1 20253 Mar 2026 - H1 2025 revenue up 3%, EBITDA up 450%, ARR up 5%, with positive outlook despite headwinds.AGILC
Q2 20253 Mar 2026 - Q3 2025 saw stable revenue, 7% ARR growth, improved EBITDA, and halved churn.AGILC
Q3 20253 Mar 2026 - 2025 saw strong ARR and EBITDA growth, with 2026 guidance aiming for further ARR gains.AGILC
Q4 202526 Feb 2026